Wir überwinden Grenzen

Patient event on September 20, 2023 / Experts from the Medical Center - University of Freiburg present new immunotherapy options

Multiple sclerosis (MS) is one of the most common neurological diseases in people between the ages of 20 and 40. Although the disease is not yet completely curable, the increasing selection of immunotherapies enables new treatment concepts and helps to slow down the progression of the disease early and highly effectively. Experts from the Department of Neurology and Neuroscience at the Medical Center - University of Freiburg will be providing information on the selection of the right individual therapy and other important topics at a patient event on

Wednesday, September 20 from
5 p.m. to 8:30 p.m. at
Hörsaal Killianstraße
Medical Center - University of Freiburg, Killianstraße 5 in Freiburg.

There will be plenty of time for questions and discussion. Admission is free.

Participation in the hybrid event is possible on site and online. Registration is essential for on-site participation. The detailed program, the registration form and the link to the live broadcast can be found at www.uniklinik-freiburg.de/ms-patiententag

Multiple sclerosis - a disease with many faces

More than 280,000 people in Germany live with multiple sclerosis (MS), an inflammatory disease of the brain and spinal cord. Women are affected about twice as often as men. Visual and sensory disorders of the skin often occur first. Later, paralysis and psychological changes such as depression can occur. There are two basic forms of the disease: chronic or relapsing-remitting. However, both forms often merge into one another.